Greenberg Traurig (GT) is a proud sponsor of ACI's 28th Annual Drug & Medical Device Litigation Conference, which brings together hundreds of products liability defense professionals to collaborate and strategize on the current industry landscape as well as take a look into what is on the horizon. Attendees will connect and share invaluable insights to conquer the latest products liability litigation challenges facing the drug and medical device community. This year's conference will consist of 20 conference sessions that will provide critical information on products liability and medical device topics, discussions on products liability risks of AI-usage in drug and medical device development, an assessment of the year's most complex MDLs, networking opportunities, and more.
On December 5, Sara K. Thompson will moderate a panel titled, "Drug and Medical Device Year in Review: Shining a Light on the Top 10 Court Cases Impacting the Life Sciences Product Liability Sphere in 2023," Libby Stennes will speak on a panel titled, "Spotlight on PFAS: Addressing Emerging Threats of Litigation Arising from Forever Chemicals," and Thomas R. Pack will give opening remarks at the GT-sponsored luncheon. GT is co-hosting the ACI Drug & Medical Device Reception taking place at R Lounge in Times Square.